Tokyo, Japan

Taiki Hamabata

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Taiki Hamabata: Innovator in Therapeutic Agents for Inflammatory and Allergic Diseases

Introduction

Taiki Hamabata is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medical science, particularly in the development of therapeutic agents for inflammatory and allergic diseases. His innovative work aims to provide effective solutions for conditions that affect millions of people worldwide.

Latest Patents

Taiki Hamabata holds a patent for a therapeutic, preventive, or improvement agent for inflammatory disease and allergic disease. The patent focuses on a novel agent that utilizes (±) 5,6-dihydroxy-8Z,11Z,14Z,17Z-eicosatetraenoic acid (5,6-DiHETE) as an active ingredient. This invention addresses the need for effective treatments for inflammatory diseases, particularly those caused by increased calcium concentration in vascular endothelial cells. The agent is designed to treat, prevent, or improve various allergic and inflammatory conditions affecting organs such as the digestive, circulatory, respiratory, urinary, genital, brain, skin, eyes, and fat.

Career Highlights

Taiki Hamabata is affiliated with the University of Tokyo, where he conducts research and develops innovative solutions in the medical field. His work has garnered attention for its potential impact on treating common yet challenging health issues. With a focus on scientific research and practical applications, he continues to advance the understanding of inflammatory and allergic diseases.

Collaborations

Taiki Hamabata collaborates with esteemed colleagues, including Takahisa Murata and Tatsuro Nakamura. These partnerships enhance the research and development process, allowing for a multidisciplinary approach to tackling complex medical challenges.

Conclusion

Taiki Hamabata's contributions to the field of therapeutic agents for inflammatory and allergic diseases highlight his dedication to improving health outcomes. His innovative patent and collaborative efforts at the University of Tokyo position him as a key figure in medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…